Endometrial hyperplasia: classification, pathogenesis, diagnosis (a review)
OA: bronze
CC0
⤵ 3 in-corpus citations
AI-generated summary
This review classifies endometrial hyperplasia, discusses its pathogenesis, and outlines diagnostic approaches for this gynecological condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (41)
- Changes in endometrial PTEN expression throughout the human menstrual cycle via crossref
- Changes in endometrial PTEN expression throughout the human menstrual cycle via openalex
- Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance via crossref
- Hormonal pathology of the endometrium via openalex
- Hormonal pathology of the endometrium via crossref
- Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas via crossref
- Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer via openalex
- Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer via crossref
- The detection rate and the structure of pathological changes of the endometrium in women of reproductive age with endometriosis via openalex
- The detection rate and the structure of pathological changes of the endometrium in women of reproductive age with endometriosis via crossref
- Therapeutic options for management of endometrial hyperplasia via crossref
- doi:10.1093/molehr/5.12.1141 via crossref
- doi:10.1210/me.2006-0522 via crossref
- doi:10.3389/fendo.2014.00076 via crossref
- doi:10.1158/1078-0432.ccr-06-0912 via crossref
- W1967280402 via openalex
- W1982595408 via openalex
- W1984530482 via openalex
- W1998502987 via openalex
- W2012873712 via openalex
- W2030727038 via openalex
- W2033522005 via openalex
- W2038461821 via openalex
- W2043484628 via openalex
- W2122226636 via openalex
- W2135002243 via openalex
- W2185449028 via openalex
- W2327800659 via openalex
- W2753740177 via openalex
- W2761993017 via openalex
- W4237254188 via openalex
- doi:10.1055/s-0034-1396256 via crossref
- doi:10.3843/glowm.10235 via crossref
- doi:10.1016/j.ogrm.2013.01.00 via crossref
- doi:10.1002/cncr.21649 via crossref
- doi:10.1038/modpathol.3880053 via crossref
- doi:10.1677/joe.0.1690023 via crossref
- doi:10.1016/j.ajog.2008.12.012 via crossref
- doi:10.21767/2386-5180.1000198 via crossref
- doi:10.1023/b:bebm.0000008980.25653.1b via crossref
- doi:10.1002/cncr.10876 via crossref
Cited by (3)
- Correlation dependence of tissue inhibitor of metalloproteinase-1 levels and follicular fluid morphology in patients with combined (uterine myoma and endometriosis) infertility in the ART-programs 2024
- Hyperplastic processes in the endometrium: controversial and unresolved problems of the disease 2023
- Prognostic risk predictors of hyperplastic endometrial processes in women with reduced reproductive potential 2022
Source provenance
- crossref
- last seen: 2026-05-18T01:00:22.213168+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK